Zharkovsky, Anti-neurotoxic effects of tauropyrone, a taurine analogue, Advances in experimental medicine and biology 583 (2006) 499-508
28 Conversely, significant variability in the therapeutic efficacy of GLP1-RAs has been shown
Limit caffeine, alcohol, and carbonated beverages
dose adjustments are a clinical decision, not a DIY experiment
GLP-1 drugs are covered under TRICARE, and patients should talk with their doctor about this treatment option and seek prior authorization to better understand what it takes to actually access them
The potential protective effects of the medications were hidden because those in the treatment group may have more high-risk features than the patients who were not taking either medication, hiding any protective effect